Identifying and Treating Follicular Lymphoma Patients With Disease Progression

January 16, 2018
Jane N. Winter, MD

Jane N. Winter, MD, professor of medicine, Division of Hematology/Oncology, Feinberg School of Medicine at Northwestern University, discusses the importance of identifying and treating patients with follicular lymphoma (FL) who experience progression of their disease. 

Jane N. Winter, MD, professor of medicine, Division of Hematology/Oncology, Feinberg School of Medicine at Northwestern University, discusses the importance of identifying and treating patients with follicular lymphoma (FL) who experience progression of their disease.

Follicular lymphoma is a rapidly changing field, Winter explains. More recently, there is evidence showing the majority of FL patients will do well, however, 20% of patients will progress within the first 2 years. These patients will have a 5-year overall survival (OS) of 50%, compared to most patients who will have a median OS measured in decades.